Gem Hopkins
Investor Relations Contact bij SILENCE THERAPEUTICS PLC
Profiel
Gem Hopkins is currently working as the VP-Investor Relations & Corporate Communications at Silence Therapeutics Plc.
Previously, Mr. Hopkins worked as the Vice President-Investor Relations at Synergy Pharmaceuticals LLC.
Actieve functies van Gem Hopkins
| Bedrijven | Functie | Begin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Investor Relations Contact | 01-08-2020 |
Eerdere bekende functies van Gem Hopkins
| Bedrijven | Functie | Einde |
|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Investor Relations Contact | 01-11-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
